SCHEMBL25540545

SCHEMBL25540545

c1ccc(-c2cc(-c3ccc4ccccc4c3)nc(-c3ccc(-c4ccc5c(c4)C(c4ccccc4)(c4ccccc4)c4c-5ccc5ccccc45)c4ccccc34)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.44
CYP1B1 Q16678 1/20 0.44
PIM1 P11309 1/20 0.38
CYP1A2 P05177 2/20 0.37
CTRC Q99895 1/20 0.36
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 4/20 0.36
MAPT P10636 4/20 0.36
HPGD P15428 4/20 0.36
MEN1 O00255 6/20 0.34
KMT2A Q03164 6/20 0.34
LMNA P02545 2/20 0.34
GLA P06280 1/20 0.34
ACACA Q13085 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TP53 P04637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
NTSR1 P30989 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25540539 0.95 ALDH1A1 (0.38) CYP1A1CYP1B1ALDH1A1KDM4EMAPT
SCHEMBL25540540 0.94 ALDH1A1 (0.38) CYP1A1CYP1B1CYP1A2ALDH1A1KDM4E
SCHEMBL25540724 0.94 ALDH1A1 (0.38) CYP1A1CYP1B1PIM1ALDH1A1KDM4E
SCHEMBL25540650 0.94 CYP1A1 (0.42) CYP1A1CYP1B1PIM1CYP1A2CTRC
SCHEMBL25540541 0.93 CYP1A1 (0.36) CYP1A1CYP1B1PIM1ALDH1A1KDM4E
SCHEMBL25540721 0.93 ALDH1A1 (0.37) CYP1A1CYP1B1ALDH1A1KDM4EMAPT
SCHEMBL25538468 0.92 CYP1A1 (0.40) CYP1A1CYP1B1PIM1CYP1A2CTRC
SCHEMBL25538626 0.91 MAPT (0.36) CYP1A1CYP1B1PIM1CYP1A2ALDH1A1
SCHEMBL25540544 0.91 MAPT (0.36) CYP1A1CYP1B1PIM1CYP1A2ALDH1A1
SCHEMBL25540718 0.91 ALDH1A1 (0.39) CYP1A1CYP1B1ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM CYP1A1 888/4885CYP1B1 1273/4885PIM1 1763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.